
Team Introduction
The team members of the company are all elites with work experience in well-known domestic pharmaceutical companies, with rich experience and professional expertise. They have a deep understanding of the research and development, production, and application of pharmaceutical intermediates, and can provide customers with comprehensive market analysis and strategic recommendations. Team members possess multilingual skills and are able to adapt to the diverse needs of the international market, establishing stable cooperative relationships with global clients. In the international market, our team has won widespread recognition from customers and provided strong support for global pharmaceutical companies with excellent product quality and innovation capabilities. In the domestic market, the team is committed to promoting the healthy development of the pharmaceutical intermediate industry with a high sense of responsibility and mission. The team has established long-term and stable cooperative relationships with many well-known domestic pharmaceutical companies, providing them with key intermediate materials for their new drug research and production.
The company has a clear organizational structure, equipped with professional production and quality management teams, and established a sound production and quality management system. It comprehensively monitors the entire process of production and testing from six aspects: "People, Machine, Material, Method, Environment, and Measurement" to ensure production stability and quality reliability. The company has now obtained certifications including HACCP, ISO9001, ISO14001 and ISO45001, achieving "full-chain compliance from raw materials to finished products".
Raw Material End: Signed quality agreements with Top 3 tier-1 suppliers, and 100% inspection is conducted for each batch of raw materials (with sample screenshot of raw material inspection report attached).
Production End: 32 quality control points are set up in key processes for real-time data collection (with "Quality Control Point Distribution Diagram" attached).
Finished Product End: Adopts "double-person review + third-party sampling inspection", with an annual qualification rate of 100%.













